Publication:
Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib

4

Suggested Citation

Noppadon Kongsuphon, Maturos Soukavanitch, Noramon Teeraaumpornpunt, Jitprapa Konmun, Touch Ativitavas, Nuttapong Ngamphaiboon Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib. Journal of Gastrointestinal Cancer. Vol.50, No.3 (2019), 601-603. doi:10.1007/s12029-018-0067-6 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/51413

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Availability

Collections